| SC 13G | 2023-02-03 | STATE STREET CORP | Adicet Bio, Inc. | - | 5.3% | EDGAR |
| SC 13G/A | 2023-01-11 | Cowen Financial Products LLC | Adicet Bio, Inc. | 3,143,608 | 7.3% | EDGAR |
| SC 13G | 2022-12-23 | EcoR1 Capital, LLC | Adicet Bio, Inc. | 3,560,700 | 8.3% | EDGAR |
| SC 13G | 2022-10-17 | RA CAPITAL MANAGEMENT, L.P. | Adicet Bio, Inc. | 2,364,351 | 5.5% | EDGAR |
| SC 13D/A | 2022-08-11 | Carlyle Group Inc. | Adicet Bio, Inc. | 2,152,959 | 5.4% | EDGAR |
| SC 13G | 2022-04-22 | Cowen Financial Products LLC | Adicet Bio, Inc. | 2,004,709 | 7.5% | EDGAR |
| SC 13G/A | 2022-02-14 | Avidity Partners Management LP | Adicet Bio, Inc. | 3,034,004 | 7.9% | EDGAR |
| SC 13G | 2021-12-15 | RTW INVESTMENTS, LP | Adicet Bio, Inc. | 3,023,744 | 7.9% | EDGAR |
| SC 13D/A | 2021-12-14 | ORBIMED ADVISORS LLC | Adicet Bio, Inc. | 6,147,599 | 15.7% | EDGAR |
| SC 13D/A | 2021-03-16 | Abingworth LLP | Adicet Bio, Inc. | 1,615,385 | 5.2% | EDGAR |
| SC 13D | 2021-03-08 | Abingworth LLP | Adicet Bio, Inc. | 1,640,721 | 5.2% | EDGAR |
| SC 13G | 2021-03-08 | Abingworth LLP | Adicet Bio, Inc. | 1,640,721 | 5.2% | EDGAR |
| SC 13G/A | 2021-02-23 | Novartis Bioventures Ltd | Adicet Bio, Inc. | 1,078,116 | 3.4% | EDGAR |
| SC 13D/A | 2021-02-19 | ORBIMED ADVISORS LLC | Adicet Bio, Inc. | 5,933,314 | 18.9% | EDGAR |
| SC 13D/A | 2021-02-18 | Schindel Yair Chaim | Adicet Bio, Inc. | 1,214,907 | 3.9% | EDGAR |
| SC 13G | 2021-02-12 | Avidity Partners Management LP | Adicet Bio, Inc. | 1,860,000 | 9.5% | EDGAR |
| SC 13G/A | 2021-02-01 | Novartis Bioventures Ltd | Adicet Bio, Inc. | 980,105 | 5.0% | EDGAR |
| SC 13D/A | 2020-12-03 | Schindel Yair Chaim | Adicet Bio, Inc. | 1,104,460 | 5.6% | EDGAR |
| SC 13D | 2020-09-24 | Schindel Yair Chaim | Adicet Bio, Inc. | 1,104,460 | 5.7% | EDGAR |
| SC 13G/A | 2020-09-22 | Novartis Bioventures Ltd | Adicet Bio, Inc. | 965,990 | 4.9% | EDGAR |